Comparison

Tyrphostin AG 490 European Partner

Item no. ALO-T-700-5x5mg
Manufacturer Alomone
CASRN 134036-52-5
Amount 5 x 5 mg
Quantity options 5 mg 5 x 5 mg
Category
Type Small Molecules
Format Lyophilized
Specific against other
Purity >99%
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Shipping Condition Room temperature
Available
Manufacturer - Type
Non Antibodies
Manufacturer - Category
S. Molecules
Manufacturer - Targets
JAK
Country of Origin
Israel
Shipping Temperature
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C
Storage Conditions
Storage as Solution: Up to two weeks at 4°C or six months at -20°C.
Molecular Weight
294, 31
Manufacturer - Format
Lyophilized Powder
Short description
A JAK Inhibitor
Description
A JAK Inhibitor
Reconstitution
DMSO. Centrifuge all product preparations before use (10000 x g 5 min).
PH
7, 4
UNSPSC
41116134
Effective Concentration
10 nM - 1 µM.
Activity
Tyrphostin AG 490 is a potent inhibitor of JAK2 and JAK3. In addition, Tyrphostin AG 490 inhibits the JAK3/STAT, JAK3/AP-1, and JAK3/MAPK pathways and their cellular consequences1.
Solubility
DMSO. Centrifuge all product preparations before use (10000 x g 5 min).
Bioassay tested
Yes
Chemical Name
(E)-2-Cyano-3-(3, 4-dihydrophenyl)-N-(phenylmethyl)-2-propenamide.
Scientific Background
Tyrphostin AG-490 (AG-490) is synthetic tyrphostin derived from benzylidine malononitrile.1 At relatively low concentrations, AG-490 was found to be a highly efficient tyrosine kinase inhibitor for hyperactive forms of Jun kinase 2, 3 and 5 (Jak 2, 3, and 5).While many kinase inhibitors are often promiscuous in the enzymes they target, AG-490 is unique in that it does not inhibit other lymphocytic tyrosine kinases such as Lck, Lyn, Btk, Syk, Src, Jak1, Zap70 or Tyk2. 2-6 AG-490 has also been shown to inhibit cytokine-induced activation of JAK2 in eosinophils stimulated with granulocyte-macrophage and in vascular smooth muscle cells and cardiac myocytes activated by angiotensin II. 7-9Some studies have demonstrated that AG-490 efficiently blocks STAT3 activation in mycosis fungoides-derived T cell lymphoma cells and induces apoptosis in myeloma cells.10-11

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 x 5 mg
Available: In stock
available

Delivery expected until 12/4/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close